Breast cancer
Results
Phase 2
This study looked at a new drug called irosustat with another hormone therapy used to treat breast cancer called .
It was for women whose cancer:
had spread to the surrounding tissue (locally advanced) or to another part of the body (secondary breast cancer)
was (ER positive)
Cancer Research UK supported this study.
Recruitment start: 22 October 2012
Recruitment end: 7 March 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Carlo Palmieri
Cancer Research UK
Experimental Cancer Medicine Centre (ECMC)
Ipsen
National Institute for Health Research Cancer Research Network (NCRN)
This is Cancer Research UK trial number CRUK/11/025.
Last reviewed: 10 October 2017
CRUK internal database number: 8278
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
